Collectively, these data point at enhanced capacity for the generation of adenosine in PASMCs from iPAH patients in addition to increased altered expression of adenosine receptors leading to increased ADORA2B, but reduced ADORA2A. The gene discussed is ADORA2A; the disease is idiopathic pulmonary arterial hypertension.